<?xml version="1.0" encoding="UTF-8"?>
<p id="Par31">Respiratory viral infections are responsible for significant morbidity and mortality in children and adults worldwide. They also predispose individuals to secondary bacterial infections by altering the innate and adaptive immune systems [
 <xref ref-type="bibr" rid="CR21">21</xref>]. Enhancing immune function through the consumption of probiotics could thus improve the outcomes of such infections [
 <xref ref-type="bibr" rid="CR22">22</xref>]. We have already shown that 
 <italic>L. paracasei</italic> CNCMI-1518 may exert such benefits by modulating host immune responses during IAV infection in a mouse model [
 <xref ref-type="bibr" rid="CR15">15</xref>].
</p>
